interleukin
il
recent
identifi
cytokin
famili
potent
immunosuppress
cytokin
secret
regulatori
treg
cell
newli
report
regulatori
b
breg
cell
function
crucial
immunosuppress
factor
immunemedi
diseas
predomin
mechan
suppress
abil
suppress
cell
prolifer
effector
function
pathogen
process
noncytopath
hepat
b
viru
hbv
infectionrel
liver
diseas
immunemedi
includ
liver
damag
viral
control
found
detect
peripher
cell
chronic
hbvinfect
patient
wherea
undetect
healthi
individu
grow
evid
cytokinemedi
immun
respons
play
pivot
role
determin
clinic
outcom
hbv
infect
particularli
import
investig
effect
immunopathogenesi
chronic
hbv
infect
studi
recent
understand
issu
discuss
interleukin
il
recent
identifi
heterodimer
cytokin
belong
cytokin
famili
compos
subunit
chain
epsteinbarr
viru
ebv
induc
gene
chain
first
report
heterodim
intern
congress
immunolog
rio
de
janeiro
brazil
studi
focus
studi
investig
characterist
associ
chronic
hepat
b
viru
hbv
infect
cytokin
famili
includ
famili
consist
heterodimer
cytokin
import
characterist
famili
chainshar
cytokin
receptor
cytokin
heterodimer
protein
compos
two
subunit
chain
chain
exampl
compos
subunit
wherea
bind
form
bind
form
famili
consist
five
differ
subunit
receptor
receptor
receptor
receptor
also
known
receptor
famili
also
follow
chainshar
charact
sever
cytokin
use
receptor
chain
form
receptor
compos
form
receptor
receptor
compos
unusu
also
anoth
two
receptor
homodim
anoth
kinas
jak
signal
transduc
activ
transcript
stat
famili
consist
downstream
signal
transduct
pathway
receptor
first
identifi
ebvinfect
b
lymphoblastoid
cell
line
homologu
report
bind
subunit
form
heterodimer
hematopoietin
transfect
cell
vitro
heterodim
construct
purifi
identifi
cytokin
vitro
offici
name
intern
union
immunolog
societi
subcommitte
interleukin
nomenclatur
human
genom
organis
hugo
gene
nomenclatur
committe
subsequ
report
secret
forkhead
box
protein
regulatori
treg
cell
inhibitori
cytokin
besid
treg
cell
activ
dendrit
cell
dc
macrophag
endotheli
cell
aortic
smooth
muscl
cell
also
express
il
sinc
discoveri
biolog
function
gradual
illumin
recent
year
determin
crucial
cytokin
famili
despit
common
structur
cytokin
receptor
well
downstream
signal
compon
biolog
activ
famili
member
extent
quit
divers
consensu
reach
mainli
proinflammatori
prostimulatori
cytokin
play
vital
role
differenti
helper
th
cell
respect
immuneregulatori
cytokin
proinflammatori
antiinflammatori
effect
howev
biolog
activ
newli
identifi
distinct
strictli
speak
potenti
immunosuppress
cytokin
produc
treg
cell
recent
report
regulatori
b
breg
cell
treg
cell
special
subset
cell
indispens
regul
immunemedi
diseas
autoinflammatori
diseas
tumorigenesi
certain
infect
natur
occur
thymusderiv
treg
cell
name
natur
treg
ntreg
cell
small
popul
ntreg
cell
subgroup
cell
abil
maintain
immun
homeostasi
vivo
convers
nontreg
cell
suppress
cell
process
call
infecti
toler
treg
cell
import
regul
infecti
toler
via
abil
convert
convent
cell
induc
treg
itreg
cell
directli
product
suppress
cytokin
transform
growth
factor
tgf
via
dc
indirectli
type
treg
type
treg
cell
alreadi
report
accord
cytokin
induc
potent
suppress
biolog
activ
vitro
vivo
convent
human
mous
cell
treat
inhibitori
cytokin
gener
new
type
itreg
cell
differ
itreg
cell
treg
cell
name
cell
mediat
immunosuppress
function
via
via
inhibitori
unusu
transcript
factor
express
requir
cell
recent
shen
et
al
found
autoimmun
infecti
diseas
b
cell
function
crucial
mediat
neg
regul
immun
mice
lack
express
b
cell
recov
experiment
autoimmun
encephalomyel
cellmedi
demyelin
autoimmun
diseas
howev
mice
show
obvious
improv
resist
infect
intracellular
bacteri
pathogen
salmonella
enterica
serovar
typhimurium
compar
mice
wildtyp
b
cell
wang
et
al
switch
inflamm
rodent
model
autoimmun
wherea
absenc
b
cell
enhanc
surviv
infect
pathogen
indic
potenti
therapeut
valu
target
human
autoimmun
infecti
diseas
two
studi
taken
investig
new
height
chronic
hbv
infect
lead
caus
liver
fibrosi
cirrhosi
even
hepatocellular
carcinoma
contribut
major
health
threat
major
econom
burden
world
despit
signific
progress
vaccin
antivir
therapi
past
decad
estim
two
billion
peopl
worldwid
infect
million
chronic
hbv
carrier
global
burden
diseas
studi
hbv
infect
rank
top
health
prioriti
world
lead
caus
death
death
per
year
hbv
noncytopath
viru
hbvrelat
liver
damag
viral
control
immunemedi
natur
histori
chronic
hepat
b
gener
divid
four
phase
immun
toler
phase
immun
clearanc
phase
low
replic
inact
carrier
stage
reactiv
phase
grow
evid
cytokinemedi
immun
respons
play
import
role
determin
clinic
outcom
hbv
infect
immunosuppress
cytokin
predomin
mechan
suppress
associ
activ
abil
inhibit
cell
differenti
effector
function
play
critic
role
varieti
diseas
inflammatori
bowel
diseas
celldepend
coliti
central
nervou
system
demyelin
smokingrel
lung
inflamm
autoimmun
diabet
coronari
arteri
diseas
autoimmun
encephalomyel
base
abovement
studi
immunemedi
diseas
abund
reason
believ
might
play
pivot
role
immunopathogenesi
hbv
infect
relat
liver
diseas
especi
develop
immun
toler
phase
persist
chronic
hbv
infect
howev
studi
focus
associ
hbv
infect
far
thu
studi
need
elucid
role
hbv
infect
relat
lesion
field
viral
hepat
liver
diseas
langhan
et
al
report
core
antigen
hepat
c
viru
hcv
could
induc
gener
rel
high
level
hcv
corespecif
treg
cell
patient
chronic
hepat
c
hcv
corespecif
treg
cell
could
suppress
report
cell
via
product
indic
potenti
abil
inhibit
virusspecif
cell
respons
lead
persist
chronic
hcv
infect
liu
et
al
provid
first
research
data
detect
circul
cell
chronic
hbvinfect
patient
wherea
undetect
healthi
control
liu
et
al
show
mrna
express
protein
secret
detect
circul
cell
patient
chronic
hepat
b
suggest
hbv
could
also
act
induc
cell
initi
secret
studi
primari
biliari
cirrhosi
tsuda
et
al
delet
gene
encod
subunit
dominantneg
receptor
type
ii
mice
result
strain
found
strikingli
high
frequenc
liver
fibrosi
mice
suggest
possibl
correl
liver
fibrosi
wang
et
al
investig
chang
express
patient
liver
cirrhosisrel
portal
hypertens
complic
esophag
varic
bleed
splenomegali
phase
joint
intervent
surgic
intervent
treat
complic
decompens
liver
cirrhosi
show
circul
concentr
obvious
reduc
effici
surgic
intervent
serum
level
posit
correl
total
bilirubin
level
intern
normal
ratio
neg
correl
albumin
level
indic
might
correl
deterior
liver
cirrhosi
conclus
recent
identifi
cytokin
famili
induc
gener
cell
breg
cell
function
immunosuppress
factor
immunemedi
diseas
advanc
understand
immunosuppress
mechan
possibl
design
target
immunotherapi
antiviru
approach
modul
immun
respons
control
persist
chronic
hbv
infect
deterior
liver
diseas
